Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Medigene AG buy DerAlmanach100000

Start price
€0.068
08.05.25 / 100%
Target price
-
08.05.28
Performance (%)
59.76%
End price
€0.11
15.05.25
Summary
This prediction ended on 15.05.25 with a price of €0.11. The BUY prediction by DerAlmanach100000 for Medigene AG saw massive gains of 59.76%. DerAlmanach100000 has a follow-up prediction for Medigene AG where he still thinks Medigene AG is a Buy. DerAlmanach100000 has 100% into this prediction
Performance without dividends (%)
Name 1w 1m
Medigene AG -6.250% -6.250%
iShares Core DAX® 1.803% 0.496%
iShares Nasdaq 100 0.429% -0.410%
iShares Nikkei 225® 0.708% -3.799%
iShares S&P 500 0.288% -0.218%

According to DerAlmanach100000 what are the pros and cons of Medigene AG for the foreseeable future?

Pros
Well known brand
Undervalued
Strong uniques
Very Future proof/growth oriented business model
Very differentiated customer and product portfolio
Market Leader or Top 3
Revenue growth > 30% per year expected
High Investments for future growth
Leading role in innovation
Cons

Comments by DerAlmanach100000 for this prediction

In the thread Trading Medigene AG
Prediction Buy
Perf. (%) 59.76%
Target price
Change
Ends at 08.05.28

Buy beendet

Current prediction by DerAlmanach100000 for Medigene AG

buy
Medigene AG

Start price
Target price
Perf. (%)
€0.030
02:55
-
11.01.26
-
10.12.25

Well known brand
Undervalued
Strong uniques
Very Future proof/growth oriented business model

Stopped prediction by DerAlmanach100000 for Medigene AG

buy
Medigene AG

Start price
Target price
Perf. (%)
€0.11
17.05.25
-
17.05.28
-72.85%
02:55

Well known brand
Undervalued
Strong uniques
Very Future proof/growth oriented business model
buy
Medigene AG

Start price
Target price
Perf. (%)
€1.57
19.03.25
-
19.03.26
-95.70%
08.05.25

Well known brand
Undervalued
Strong uniques
Very Future proof/growth oriented business model